General MedicationsORALStandard

RALTEGRAVIR POTASSIUM

Standard Dose

EQ 600MG BASE

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview RALTEGRAVIR POTASSIUM is listed in Drugs@FDA under application 217990 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient RALTEGRAVIR POTASSIUM Form and strength TABLET;ORAL - EQ 600MG BASE Sponsor LUPIN LTD Submission history Latest submission status date: 2025-05-06 00:00:00.

Structured Monograph

Clinical summary

Approval overview RALTEGRAVIR POTASSIUM is listed in Drugs@FDA under application 217990 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient RALTEGRAVIR POTASSIUM Form and strength TABLET;ORAL - EQ 600MG BASE Sponsor LUPIN LTD Submission history Latest submission status date: 2025-05-06 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.